Complete blood count | | | HBV and HCV serology |
WBC | 6,700/μL | ChE | 292 IU/L | HBsAg | (-) |
RBC | 480 ×104/μL | LDH | 261 IU/L | HBsAb | (-) |
Hb | 14.1 g/dL | T-Chol | 245 mg/dL | HBeAg | (-) |
Hct | 43.0 % | TP | 7.4 g/dL | HBeAb | (-) |
Plt | 24.9 ×104/μL | Alb | 4.3 g/dL | HBcAb | (-) |
| | | Na | 139 mEq/L | HCVAb | (-) |
Coagulation tests | K | 4.8 mEq/L | | |
PT-INR | 0.99 | Cl | 101 mEq/L | Tumor markers |
APTT | 32.3 sec | Ca | 9.4 mg/dL | AFP | 46,300 ng/mL |
Blood chemistry | UA | 7.9 mg/dL | PIVKA-II | 28,555mAU/mL |
AST | 104 IU/L | UN | 17.6 mg/dL | | |
ALT | 68 IU/L | Cr | 1.25 mg/dL | Dye clearance test |
ALP | 353 IU/L | CRP | 0.28 mg/dL | ICG-R 15 | 14.5 % |
γGTP | 175 IU/L | HbA1c | 7.5 % | | |
T.Bil | 0.8 mg/dL | eGFR | 43.7 mL/min/1.73 m2
| | |
-
AFP alpha-fetoprotein, Alb albumin, ALT alanine aminotransferase, ALP alkaline phosphatase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, ChE cholinesterase, CRP C-reactive protein, eGFR estimated glomerular filtration rate, γGTP gamma glutamyl transpeptidase, HBV hepatitis B virus, Hb hemoglobin, HbA1c hemoglobin A1c, Hct hematocrit, HCV hepatitis C virus, ICG-R 15 indocyanine green dye retention rate at 15 min, LDH lactate dehydrogenase, Plt platelets, PT-INR prothrombin time-international normalized ratio, RBC red blood cells, T.Bil total bilirubin, T.Chol total cholesterol, PIVKA-II protein induced by vitamin K absence or antagonist, TP total protein, UA uric acid, UN urea nitrogen, WBC white blood cells
